Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease

NACompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

June 22, 2021

Study Completion Date

June 22, 2021

Conditions
Multiple MyelomaAmyloidosis
Interventions
DRUG

Tacrolimus

Tacrolimus starting on Day -1

DRUG

Equine Anti-thymocyte globulin

20 mg/kg IV on Days -3, -1, +1, +3

PROCEDURE

Kidney transplant from a related donor

On Day 0 the renal transplant is performed according to standard surgical techniques.

DRUG

Bone marrow transplant from a related donor

Donor bone marrow (\> 2 x 10e8 nucleated cells/kg of recipient body weight) is prepared for infusion according to the standard procedure. The infusion begins in the operating room as soon as the vascular anastomosis of the renal allograft has been completed.

RADIATION

Total body irradiation 400 centigray (200 cGy X 2)

On transplant day -1

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT02158052 - Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease | Biotech Hunter | Biotech Hunter